REG - GlaxoSmithKline PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">GSK.L</Origin>

GSKAnnouncement

16/10/2017 16:45

RNS Number : 7369T
GlaxoSmithKline PLC
16 October 2017
GlaxoSmithKline plc(the'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr D E Troy 
b)
Position/status
SVP & General Counsel
c)
Initial notification/
amendment
Initial notification
2. 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name 
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Descriptionofthefinancial instrument
American Depositary Shares ('ADSs')
ISIN: US37733W1053
b)
Natureofthetransaction
Acquisition of ADSs following the re-investment of dividends paid to shareholders on 12 October 2017 on ADSs held in the Company's US Deferred Performance Share Plan.
c)
Price(s)and 
volume(s)
Price(s)
Volume(s)
$41.02
377.925
$41.02
5.824
d)
Aggregated
information
AggregatedvolumePrice
383.749
$41.02
e)
Date ofthetransaction
2017-10-12
f)
Placeofthe transaction
New York Stock Exchange (XNYS)

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHEQLFFDBFXFBD